164 related articles for article (PubMed ID: 2441573)
1. CSF-amine metabolites in depression, dementia and in controls.
Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
[TBL] [Abstract][Full Text] [Related]
2. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
Malm J; Kristensen B; Ekstedt J; Wester P
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
[TBL] [Abstract][Full Text] [Related]
3. Monoamine metabolites in CSF and suicidal behavior.
Träskman L; Asberg M; Bertilsson L; Sjöstrand L
Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
[TBL] [Abstract][Full Text] [Related]
4. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
5. CSF monoamine metabolites in chronic pain.
France RD; Urban BJ; Pelton S; Kilts CD; Hong JS; Nemeroff CB
Pain; 1987 Nov; 31(2):189-198. PubMed ID: 2448727
[TBL] [Abstract][Full Text] [Related]
6. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
Odink J; Kärkelä J; Thissen JT; Marnela KM
Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
8. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus.
Gopal SC; Pandey A; Das I; Gangopadhyay AN; Upadhyaya VD; Chansuria JP; Singh TB
Childs Nerv Syst; 2008 Jun; 24(6):713-6. PubMed ID: 18075745
[TBL] [Abstract][Full Text] [Related]
10. CSF amine metabolites and depression.
Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
[TBL] [Abstract][Full Text] [Related]
11. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
13. CSF amine metabolites in depression.
Reddy PL; Khanna S; Subhash MN; Channabasavanna SM; Rao BS
Biol Psychiatry; 1992 Jan; 31(2):112-8. PubMed ID: 1371076
[TBL] [Abstract][Full Text] [Related]
14. Monoamine metabolites in the CSF of epileptic patients.
Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
[TBL] [Abstract][Full Text] [Related]
15. CSF monoamine metabolites, depression, and suicide.
Asberg M; Bertilsson L; Mårtensson B
Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
[No Abstract] [Full Text] [Related]
16. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
17. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
Beckmann H; Waldmeier P; Lauber J; Gattaz WF
J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
[TBL] [Abstract][Full Text] [Related]
18. Reduction of biogenic amine levels in the Rett syndrome.
Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
[TBL] [Abstract][Full Text] [Related]
19. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
Gibbons RD; Davis JM
Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
[TBL] [Abstract][Full Text] [Related]
20. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.
Hovi-Viander M; Kanto J; Scheinin H; Scheinin M
Br J Clin Pharmacol; 1985 Nov; 20(5):492-6. PubMed ID: 2416331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
